SCHEMBL29669296

SCHEMBL29669296

CS(=O)(=O)Nc1nc2nc(NC3CCOCC3)ncc2cc1Oc1ccc(F)cc1F

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 14/20 0.62
MAPK8 P45983 7/20 0.61
GAK O14976 1/20 0.61
RPS6KA4 O75676 1/20 0.61
PRKD3 O94806 1/20 0.61
MAP4K4 O95819 1/20 0.61
MAPK1 P28482 1/20 0.61
MAPK9 P45984 1/20 0.61
CSNK1D P48730 1/20 0.61
RPS6KA3 P51812 1/20 0.61
MAPK10 P53779 1/20 0.61
DDR1 Q08345 1/20 0.61
MAPK11 Q15759 1/20 0.61
TAOK1 Q7L7X3 1/20 0.61
COQ8A Q8NI60 1/20 0.61
PRKD2 Q9BZL6 1/20 0.61
STK36 Q9NRP7 1/20 0.61
NLK Q9UBE8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5112893 1.00 MAPK14 (0.62) MAPK14MAPK8GAKRPS6KA4PRKD3
SCHEMBL14014987 0.83 MAPK14 (0.66) MAPK14MAPK8GAKRPS6KA4PRKD3
SCHEMBL29594951 0.83 MAPK14 (0.57) MAPK14MAPK8GAKRPS6KA4PRKD3
SCHEMBL5107303 0.83 MAPK14 (0.57) MAPK14MAPK8GAKRPS6KA4PRKD3
SCHEMBL5122174 0.77 MAPK8 (0.43) MAPK14MAPK8MAPK9MAPK10MAPK11
R-1487 SCHEMBL5120612 0.76 MAPK14 (1.00) MAPK14MAPK8GAKRPS6KA4PRKD3
R-1487 SCHEMBL29527296 0.76 MAPK14 (1.00) MAPK14MAPK8GAKRPS6KA4PRKD3
R-1487 SCHEMBL20582726 0.76 MAPK14 (0.98) MAPK14MAPK8GAKRPS6KA4PRKD3
R-1487 SCHEMBL31119050 0.76 MAPK14 (0.98) MAPK14MAPK8GAKRPS6KA4PRKD3
SCHEMBL29594531 0.75 MAPK14 (0.82) MAPK14MAPK8GAKRPS6KA4PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-09-24 CN disclosed
CN-114732910-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-08-23 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed